Covid-19 and Anosmia: Study

SARS-CoV-2 Infection/Covid-19 and Anosmia – Prevalence Study, Molecular Analysis and Clinical Trial

Researchers at University College London, led by Professor Valerie J. Lund, CBE and Mr Matt Lechner, and in close collaboration with Professor Carl Philpott from the University of East Anglia, have begun a multi-centre clinical trial investigating the loss of the sense of smell in COVID-19 patients.

The study aims to determine the prevalence of this symptom in those who have experienced the COVID-19 infection, the extent of smell loss and related smell and taste dysfunction, as well as the impact of the symptom on daily life. The study also consists of a randomised controlled trial for eligible participants, which is investigating the potential for smell training as treatment.

Ultimately, the researchers hope to utilise this study to gain a better understanding of the impact of smell loss in COVID-19 patients and inform the way in which we manage this in the future.

This study is open to all adults, who have been infected with COVID-19, have experienced a loss of sense of smell and have not previously undertaken smell training of any kind. The study has been approved by an NHS HRA Research Ethics Committee (IRAS No. 283758). Participation is completely voluntary.

If you interested in participating, please contact Miss Jacklyn Liu: regmjwj@ucl.ac.uk